Clin Res Cardiol (2021)
DOI DOI https://doi.org/10.1007/s00392-021-01843-w

Prevalence and time course of arrhythmia-induced cardiomyopathy in patients with newly diagnosed heart failure and concomitant tachyarrhythmia – the TACHY-HF-Pilot-Trial
C. Schach1, T. Körtl1, B. Harler2, F. Mühleck3, P. Baum3, C. Meindl1, F. Zeman4, M. Koller4, M. Resch5, A. Bäßler1, R. Wachter3, L. S. Maier1, S. T. Sossalla1
1Abteilung für Kardiologie, Universitäres Herzzentrum Regensburg, Regensburg; 22. Medizinische Abteilung - Kardiologie und Nephrologie, Landesklinikum Wiener Neustadt, Wiener Neustadt, AT; 3Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig; 4Zentrum für klinische Studien, Universitätsklinikum Regensburg, Regensburg; 5Klinik für Innere Medizin, Caritas Krankenhaus St. Josef, Regensburg;
Background: Arrhythmias may often be a result of heart failure, but they can also cause left-ventricular systolic dysfunction (LVSD), thereby presenting as arrhythmia-induced cardiomyopathy (AIC). AIC-diagnosis is established retrospectively when LVSD normalizes or improves significantly over time following rhythm restoration. However, the prevalence and most importantly the time course of this relevant disease remain unclear and hence merit investigation to enable the correct diagnosis. Therefore, our aim was to evaluate a) the occurrence of AIC in the clinical relevant cohort of patients with newly diagnosed and otherwise unexplainable LVSD with concomitant tachycardia and b) the time needed to fulfill the diagnostic criteria of AIC in order to facilitate a diagnostic algorithm.


Method: We prospectively screened patients hospitalized for newly diagnosed and otherwise unexplainable LVSD (ejection fraction, EF, <50%) and coinciding tachyarrhythmia. Coronary angiography and cardiac magnetic resonance imaging were performed to exclude other causes for LVSD. During the initial stay, patients underwent a rhythm control strategy in accordance to the locally implemented clinical pathways. LVEF was assessed by echocardiography at presentation, before discharge and at follow-up (FU) visits after 2, 4, and 6 months. Patients, who lost sinus rhythm during FU, were excluded from our analysis. Patients with any increase of ≥15% in absolute EF or an EF
50% with an absolute improvement of ≥10% after 6 months of FU were assigned to the AIC-group, which is a common definition of AIC. All others were assigned to an idiopathic DCM-group as final comparator.


Results: 63 patients were eligible, 13 of them presented with recurrent arrhythmia and were excluded for this analysis. Thus, our sample consists of a total of 50 patients. 39 of 50 patients have completed all FU visits so far and their results are reported in this interim analysis. At presentation, mean±SD heart rate (HR) was 121±17/min. After rhythm therapy, HR was normalized to 66.7±10/min. The development of EF in AIC and DCM patients can be seen in Fig. 1. Surprisingly, only 6 patients did not fulfill the AIC-criteria in this specific collective resulting in a prevalence of 84.6% (95%-CI: 69.5% – 94.1%). This high prevalence of AIC clearly underlines the importance of the disease. Two and 4 months after rhythm intervention, 57.5% and 72.5% of patients fullfilled AIC-criteria (see Fig. 2). The sensitivity for detection of AIC via echocardiographic measurement of EF at months 2 and 4 of FU was 65.0% and 85.7% with a specificity of 100%, emphasizing that a FU of 6 months is necessary to certainly distinguish between AIC and idiopathic DCM.


Conclusion: In this prospective trial we demonstrate, that the prevalence of AIC in the clinically relevant patient collective with newly diagnosed and otherwise unexplainable LVSD with concomitant tachycardia is higher than expected. Analysis of the time course of AIC clearly suggests that diagnosis cannot be established before 6 months of follow-up after successful rhythm restoration. These results may help to improve diagnosis of AIC in daily clinical practice.




https://dgk.org/kongress_programme/jt2021/aV474.html